Upcoming Webinars

From Concept to Market – Unique approaches in Biomanufacturing

Presented by Jincai Li, Vice President of WuXi Biologics and Kevin Mullen, Sr. Product Manager, Single-Use Systems at Thermo Fisher Scientific
18th September 2019


How to Utilize Design of Experiments (DoE) Principles for the Development of High Throughput, Robust Methods for the Assessment of Product Quality

Presented by Jeremy Springall PhD, Scientist II, Analytical Sciences, R&D Biopharmaceutical Development, AstraZeneca
19th September 2019


Characterization of Biotherapeutics

Presented by Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia and Dr Kai Scheffler, Product Manager at Thermo Fisher Scientific
24th September 2019


Implementation Of An Affordable And Scalable Manufacturing Strategy For Gene Therapy Products

Presented by Bastiaan Leewis, MSAT manager of Industrialization at MeiraGTx and Ankita Desai, Bioprocess Field Application Specialist at Eppendorf
25th September 2019


Cost Considerations for the Application of Continuous Processing

Presented by Narasimha Rao Nedunuri, CEO of CLONZ Biotech and José Castillo, PhD, CTo and co-founder of Univercells
02nd October 2019


Qualification of Raw Materials Used In the Manufacturing of Cellular Therapies

Presented by Jim Richardson, Sr Scientific Liaison at United States Pharmacopeia and Horst Ruppach, Ph.D. Scientific Director Viral Safety at Charles River
07th October 2019


FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing

Presented by Lily Koo, Consumer Safety Officer at Food and Drug Administration
16th October 2019


Upstream Viral Risk Mitigation Strategy for High Titer Biologics Manufacturing

Presented by Aaron Mack, Engineer at Biogen and Dave Kolwyck, Director Materials Science at Biogen and David Gemmel Senior Process Engineer at Merck
17th October 2019


Engineering First Principles: Applications to Pharmaceutical Manufacturing

Presented by Bernard McGarvey, PhD Chemical Engineering
05th November 2019


Just in Time Release of Car-T Cell Therapies

Presented by Irving Ford, Head of CAR T QC Laboratories at Celgene and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
11th November 2019


Biopharmaceutical Process Model Evolution – Enabling Process Knowledge Continuum from an Advanced Process Control Perspective

Presented by Saly Romero-Torres, PhD, Senior Manager, Advanced Data Analytics, Biogen and David Lovett, Managing Director & John Mack, Engineering Director at Perceptive Engineering
15th November 2019


Biopharmaceutical process development – Trends/ Challenges/Opportunities

Presented by Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd
20th November 2019


Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence?

Presented by Petra Booij, Investigator at GlaxoSmithKline and Dr Kyle D’Silva, Pharma & BioPharma Marketing Leader, Thermo Fisher Scientific
21st November 2019


Monitoring Impurities in Biologics

Presented by Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia 
26th November 2019


Qualification of Raw Materials and Cell Substrates for Biomanufacturing

Presented by Maura C. Kibbey, Ph.D., Director, Science & Standards, Global Biologics, U.S. Pharmacopeia and Martin Wisher, PhD, Global Head of Regulatory Affairs at Merck
16th January 2020


Utility of Generating <665> Data: Drug Manufacture’s Perspective: Will USP permit such format?

Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Desmond G. Hunt, Principal Liaison at United States Pharmacopeia
21st January 2020


Identification of Approaches to Simulated Leachable Studies: What are They? When to do Them?

Presented by Jason Creasey, Analytical Chemist at GSK
03rd February 2020


mAb Industry in China : Biosimilars vs Innovative Biologics

Presented by Dr. Joe X Zhou, CEO at Genor Biopharma, Walvax Bio Group and Sarah (Xuyu) Wang, Head of Segment Marketing, Biosimilars and Bioconjugations at Sartorius Stedim Biotech
10th February 2020


High-Resolution Characterization of Structure, Interaction, and Miscibility of Drug Products

Presented by Eric Munson, PhD, Professor and Head at Purdue University
11th February 2020


Rapid Microbial Methods – Reap Benefits And Avoiding Pitfalls

Presented by Dr Andrew Bartko, Research Leader at Battelle Memorial Institute
13th February 2020


MES – Integrating Technology, Quality and Compliance – Opportunities, Challenges and Strategies.

Presented by Sachin Bhandari, GM, Head IT CSV at Sun Pharma
18th February 2020


New Technologies for Improving and Controlling Product Quality, Expression, Timelines and Yield in Upstream Process Development

Presented by Niki Wong, Principal Research Scientist at AbbVie Operations Singapore Pte Ltd
18th February 2020


Hybrid Models: The Best of Both (Mechanistic & Empirical) Worlds to Accelerate and De-Risk Process Development

Presented by Christian Airiau, PhD, Global Head Data Sciences, Biologics Development at Sanofi
19th February 2020


Harnessing the Power of Data Analytics to Derive Process Intelligence for Pharma Manufacturing

Presented by Santosh Whatkar, Senior Manager, Automation and Digital Technology at Pfizer
05th March 2020


Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up

Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen
10th March 2020


Mitigating Uncertain Times: Challenges with Rapid Detection and Characterization of Biological and Chemical Threats and Accelerated Development of Pharmaceutical Countermeasures for Unanticipated Medical Needs

Presented by Douglas E. Kiehl, Research Advisor, Bioproduct, Research & Development at Eli Lily and Company
13th March 2020


Extractable Data Mining: Common Extractables From Polymeric Manufacturing Materials Used in Biologics Production

Presented by Ping Wang, Director at Johnson & Johnson
23rd March 2020


Transformation of Toxicology data into Specific PDE’s

Presented by Kim Li, PhD, DABT, MPH, Amgen Inc
07th April 2020